Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug;7(8):655-656.
doi: 10.1016/S2213-2600(19)30136-5. Epub 2019 May 7.

Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol

Affiliations
Review

Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol

Hilary A Robbins et al. Lancet Respir Med. 2019 Aug.

Erratum in

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

CDB receives consulting fees from Medial EarlySign, LLC and GRAIL, Inc. All other authors report no conflicts of interest.

Figures

Figure:
Figure:
Infographic depicting estimated outcomes in the US National Lung Screening Trial under the Lung-RADS nodule management protocol Reproduced with permission from the International Agency for Research on Cancer; full-page infographic available at https://www.iarc.fr/infographics/benefits-and-harms-of-lung-cancer-screening/

References

    1. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365(5):395–409. - PMC - PubMed
    1. Sabia F, Sestini S, Pastorino U, et al. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: New confirmation of lung cancer screening efficacy. 2019; - PMC - PubMed
    1. The ASCO Post. WCLC 2018: NELSON Study: CT Screening for Early Lung Cancer Reduces Lung Cancer Mortality. 2018.
    1. Oudkerk M, Devaraj A, Vliegenthart R, et al. European position statement on lung cancer screening. Lancet Oncol 2017;18(12):e754–66. - PubMed
    1. Ruano-Ravina A, Pérez-Ríos M, Casàn-Clará P, Provencio-Pulla M. Low-dose CT for lung cancer screening. Lancet Oncol 2018;19(3):e131–2. - PubMed

MeSH terms